Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony T Reder

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
Ebiomedicine|October 26, 2019
Interferon-β corrects massive gene dysregulation in multiple sclerosis: Short-term and long-term effects on immune regulation and neuroprotectionXuan Feng, Riyue Bao, Lei Li, et al.
Multiple Sclerosis and Related Disorders|April 22, 2023
Effectiveness of rituximab versus oral immunosuppressive therapies in neuromyelitis optica spectrum disorder in a racially diverse cohort of subjects: A single-center retrospective studyLaura Dresser, Widad Abou Chaar, Anthony T Reder, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 17, 2009
Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon beta-1bMark A Jensen, Rachel N Yanowitch, Anthony T Reder, et al.
The Patient|August 12, 2015
Patient Preferences for Injectable Treatments for Multiple Sclerosis in the United States: A Discrete-Choice ExperimentChristine Poulos, Elizabeth Kinter, Jui-Chen Yang, et al.
Journal of Neuroimmunology|August 6, 2002
Low expression of interferon-stimulated genes in active multiple sclerosis is linked to subnormal phosphorylation of STAT1Xuan Feng, Anthony L Petraglia, Michael Chen, et al.
Archives of Neurology|July 18, 2012
Inhibition of interferon-beta responses in multiple sclerosis immune cells associated with high-dose statinsXuan Feng, Diana Han, Bharat K Kilaru, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 30, 2021
Anti-CD20 therapy corrects a CD8 regulatory T cell deficit in multiple sclerosisQuentin Howlett-Prieto, Xuan Feng, John F Kramer, et al.
Multiple Sclerosis and Related Disorders|February 11, 2023
Effectiveness of ocrelizumab on clinical and MRI outcome measures in multiple sclerosis across black and white cohorts: A single-center retrospective studyAmanda Frisosky Abuaf, Adil Javed, Samuel R Bunting, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|October 21, 2014
Induction of a unique isoform of the NCOA7 oxidation resistance gene by interferon β-1bLijian Yu, Ed Croze, Ken D Yamaguchi, et al.
Journal of Neuroimmunology|February 19, 2008
IFN-beta-regulated genes show abnormal expression in therapy-naïve relapsing-remitting MS mononuclear cells: gene expression analysis employing all reported protein-protein interactionsKen D Yamaguchi, Daniel L Ruderman, Ed Croze, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Ebiomedicine|October 26, 2019
Interferon-β corrects massive gene dysregulation in multiple sclerosis: Short-term and long-term effects on immune regulation and neuroprotectionXuan Feng, Riyue Bao, Lei Li, et al.
Multiple Sclerosis and Related Disorders|April 22, 2023
Effectiveness of rituximab versus oral immunosuppressive therapies in neuromyelitis optica spectrum disorder in a racially diverse cohort of subjects: A single-center retrospective studyLaura Dresser, Widad Abou Chaar, Anthony T Reder, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 17, 2009
Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon beta-1bMark A Jensen, Rachel N Yanowitch, Anthony T Reder, et al.
The Patient|August 12, 2015
Patient Preferences for Injectable Treatments for Multiple Sclerosis in the United States: A Discrete-Choice ExperimentChristine Poulos, Elizabeth Kinter, Jui-Chen Yang, et al.
Journal of Neuroimmunology|August 6, 2002
Low expression of interferon-stimulated genes in active multiple sclerosis is linked to subnormal phosphorylation of STAT1Xuan Feng, Anthony L Petraglia, Michael Chen, et al.
Archives of Neurology|July 18, 2012
Inhibition of interferon-beta responses in multiple sclerosis immune cells associated with high-dose statinsXuan Feng, Diana Han, Bharat K Kilaru, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 30, 2021
Anti-CD20 therapy corrects a CD8 regulatory T cell deficit in multiple sclerosisQuentin Howlett-Prieto, Xuan Feng, John F Kramer, et al.
Multiple Sclerosis and Related Disorders|February 11, 2023
Effectiveness of ocrelizumab on clinical and MRI outcome measures in multiple sclerosis across black and white cohorts: A single-center retrospective studyAmanda Frisosky Abuaf, Adil Javed, Samuel R Bunting, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|October 21, 2014
Induction of a unique isoform of the NCOA7 oxidation resistance gene by interferon β-1bLijian Yu, Ed Croze, Ken D Yamaguchi, et al.
Journal of Neuroimmunology|February 19, 2008
IFN-beta-regulated genes show abnormal expression in therapy-naïve relapsing-remitting MS mononuclear cells: gene expression analysis employing all reported protein-protein interactionsKen D Yamaguchi, Daniel L Ruderman, Ed Croze, et al.
Pageof 9